Cargando…

Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis

OBJECTIVE: Sepsis is a condition associated with a dysregulated inflammatory response to infection with significant morbidity. Recent advances have elucidated the vital role that the short chain fatty acid glycoprotein receptor 43 (FFA2/GPR43) plays in inflammatory and immunomodulatory pathways. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Zyad J., Van De Louw, Andry, Fehr, Graham, Li, Jialiu D., Kunselman, Allen, Ruiz-Velasco, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771199/
https://www.ncbi.nlm.nih.gov/pubmed/29338778
http://dx.doi.org/10.1186/s13104-018-3165-4
_version_ 1783293222380896256
author Carr, Zyad J.
Van De Louw, Andry
Fehr, Graham
Li, Jialiu D.
Kunselman, Allen
Ruiz-Velasco, Victor
author_facet Carr, Zyad J.
Van De Louw, Andry
Fehr, Graham
Li, Jialiu D.
Kunselman, Allen
Ruiz-Velasco, Victor
author_sort Carr, Zyad J.
collection PubMed
description OBJECTIVE: Sepsis is a condition associated with a dysregulated inflammatory response to infection with significant morbidity. Recent advances have elucidated the vital role that the short chain fatty acid glycoprotein receptor 43 (FFA2/GPR43) plays in inflammatory and immunomodulatory pathways. We hypothesized that elevated whole blood GPR43 RNA expression would be associated with increased 30-day survival in patients admitted with sepsis. Patients (n = 93) admitted to the intensive care unit with the diagnosis of sepsis underwent quantitative real time PCR within 48 h of intensive care unit admission. Clinical and demographical parameters were retrospectively extracted from the chart and compared to quantitative measurements of GPR43 RNA expression. RESULTS: Utilizing logistic regression, we found that the odds of mortality decreased for every one-unit increase in GPR43 RNA expression for patients that survived to 30 days [OR = 0.71; 95% CI (0.50, 0.99) p = 0.049]. Using linear regression, we determined that the increase in whole blood GPR43 expression was not associated with whole blood white cell count [r = 0.04; 95% CI (−0.16, 0.24); p = 0.70] or body mass index [r = − 0.07; 95% CI (− 0.23, 0.18); p = 0.81]. We conclude that the GPR43 receptor plays an integral role in survival during and after sepsis.
format Online
Article
Text
id pubmed-5771199
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57711992018-01-26 Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis Carr, Zyad J. Van De Louw, Andry Fehr, Graham Li, Jialiu D. Kunselman, Allen Ruiz-Velasco, Victor BMC Res Notes Research Note OBJECTIVE: Sepsis is a condition associated with a dysregulated inflammatory response to infection with significant morbidity. Recent advances have elucidated the vital role that the short chain fatty acid glycoprotein receptor 43 (FFA2/GPR43) plays in inflammatory and immunomodulatory pathways. We hypothesized that elevated whole blood GPR43 RNA expression would be associated with increased 30-day survival in patients admitted with sepsis. Patients (n = 93) admitted to the intensive care unit with the diagnosis of sepsis underwent quantitative real time PCR within 48 h of intensive care unit admission. Clinical and demographical parameters were retrospectively extracted from the chart and compared to quantitative measurements of GPR43 RNA expression. RESULTS: Utilizing logistic regression, we found that the odds of mortality decreased for every one-unit increase in GPR43 RNA expression for patients that survived to 30 days [OR = 0.71; 95% CI (0.50, 0.99) p = 0.049]. Using linear regression, we determined that the increase in whole blood GPR43 expression was not associated with whole blood white cell count [r = 0.04; 95% CI (−0.16, 0.24); p = 0.70] or body mass index [r = − 0.07; 95% CI (− 0.23, 0.18); p = 0.81]. We conclude that the GPR43 receptor plays an integral role in survival during and after sepsis. BioMed Central 2018-01-16 /pmc/articles/PMC5771199/ /pubmed/29338778 http://dx.doi.org/10.1186/s13104-018-3165-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Carr, Zyad J.
Van De Louw, Andry
Fehr, Graham
Li, Jialiu D.
Kunselman, Allen
Ruiz-Velasco, Victor
Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title_full Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title_fullStr Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title_full_unstemmed Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title_short Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
title_sort increased whole blood ffa2/gpr43 receptor expression is associated with increased 30-day survival in patients with sepsis
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771199/
https://www.ncbi.nlm.nih.gov/pubmed/29338778
http://dx.doi.org/10.1186/s13104-018-3165-4
work_keys_str_mv AT carrzyadj increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis
AT vandelouwandry increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis
AT fehrgraham increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis
AT lijialiud increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis
AT kunselmanallen increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis
AT ruizvelascovictor increasedwholebloodffa2gpr43receptorexpressionisassociatedwithincreased30daysurvivalinpatientswithsepsis